Yervoy Injectable Product

DRUG3 trials

Sponsors

Rampart Health, L.L.C., ImmunSYS, LLC

Conditions

Metastatic CancerMetastatic Prostatic Adenocarcinoma

Phase 2

A Phase 2 Trial for Men With Metastatic Prostatic Adenocarcinoma

CompletedNCT04090775

Rampart Health, L.L.C.Metastatic Prostatic Adenocarcinoma

Start: 2019-06-28End: 2022-01-31Updated: 2022-06-21

A Phase 2 Trial for Patients With Metastatic Solid Cancer

Active, not recruitingNCT04713371

Rampart Health, L.L.C.Metastatic Cancer

Start: 2021-05-19End: 2024-12-31Target: 32Updated: 2024-05-09

Metastatic Solid Cancer Clinical Trial

Active, not recruitingNCT04739618

ImmunSYS, LLCMetastatic Cancer

Start: 2021-03-04End: 2024-12-31Target: 32Updated: 2024-07-23

Related Papers

First-in-Human Phase II Clinical Trial of Multiplex IntraTumoral Immunotherapy (MITI) in Patients with Metastatic Solid Cancer (Abscopal 5001 Trial)

Cancers2025-09-12

706 First-in-human phase 2 clinical trial of multiplex combination intratumoral immunotherapy (MCII) in patients with metastatic solid cancer (Abscopal 5001 trial)

Regular and Young Investigator Award Abstracts2023-10-311 citations